We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
BIO-RAD LABORATORIES

Download Mobile App





Scientific Session Explores Role of Technology in New Era of Specimen Transport

By LabMedica International staff writers
Posted on 27 Jul 2023
Print article
Image: Plans for new CLSI documents addressing specimen preanalytics were shared at AACC 2023 (Photo courtesy of CLSI)
Image: Plans for new CLSI documents addressing specimen preanalytics were shared at AACC 2023 (Photo courtesy of CLSI)

Regardless of a lab's scale or complexity, patient samples require transportation prior to testing. From moving specimens across a room to shipping them globally, all labs inevitably encounter challenges at some point. The AACC 2023 session titled "Advances in Courier, Drone, and Automated Laboratory Transport" empowered attendees with the understanding of how issues and inefficiencies in sample transport could impact test results. Moreover, the session also threw light on how emerging technologies can be harnessed to streamline testing and maintain specimen quality.

Session moderator Joe Wiencek, Ph.D. from the Vanderbilt University School of Medicine (Nashville, TN, USA) argued that despite the critical role of patient specimens in testing, the sector hasn't paid adequate attention to specimen transport conditions. At his institution, Wiencek has employed innovative devices to record conditions during specimen transport, such as temperature, humidity, and G-forces. He expressed considerable concern over the practice at external collection sites of storing samples in outdoor lockboxes while waiting for courier pick-up, particularly given the intense heat in his region. However, in the absence of benchmarks and standards for specimen transport, it's challenging for laboratories to take proactive steps. Wiencek shared plans for new Clinical and Laboratory Standards Institute (CLSI, Berwyn, PA, USA) documents that address specimen preanalytics, particularly PRE-06 Evaluation of External Transport Systems, which he is co-authoring. The attendees left the session equipped with a set of tools to overcome their sample transport hurdles.

Timothy Amukele, MD, from ICON Clinical Research (Farmingdale, MD, USA) expanded the discussion about external sample transport by introducing the concept of medical drone transport. While medical drones might seem like a concept straight out of a science fiction novel for some, they are very much a reality in certain parts of the world. Dr. Amukele highlighted how African governments are leading the charge in harnessing these technologies effectively. He cited the example of Rwanda, where drones are used to deliver life-saving blood products to remote hospitals, along with similar implementations in other countries. Dr. Amukele believes that these success stories are noteworthy and succeeded in convincing the attendees of the viability of medical drones in specimen transportation.

However, the application of drone transportation isn't limited to isolated regions. There's considerable interest in deploying this technology in densely populated urban areas as well. Dr. Amukele shared his personal experience of spearheading a medical drone research team in the United States, shedding light on the steps required to establish a medical drone transport network. He stressed that medical drones have already shown their worth in real-world applications and expressed his wish to see their usage further expand within laboratory practice.

Jonathan Genzen, MD, Ph.D., from ARUP Laboratories (Salt Lake City, UT, USA) shifted the focus of the discussion to sample transportation and automation within healthcare facilities and laboratories. His objective at his institution is to automate routine, non-value-adding steps in the testing process, thereby allowing professionals to concentrate on complex tasks that demand human expertise. Genzen recounted his experiences in integrating automated intelligent vehicles for sample transportation. These non-track-based mobile robots are suitable for specimen distribution and are equipped with sensors to navigate their surroundings, avoiding collisions with objects and individuals. He also discussed lessons in automation derived from the COVID-19 pandemic. Attendees gained insights into how they can modernize their specimen transport procedures. Genzen emphasized that labs can implement simple, easy improvements to reap substantial benefits from minimal investments.

Related Links:
Vanderbilt University
ICON Clinical Research
ARUP Laboratories 
CLSI

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
New
Gold Member
TORCH Panel Rapid Test
Rapid TORCH Panel Test

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: The fastGEN BCR::ABL1 Cancer kit offers a way to personalize treatment strategies for leukemia (Photo courtesy of BioVendor MDx)

First of Its Kind NGS Assay for Precise Detection of BCR::ABL1 Fusion Gene to Enable Personalized Leukemia Treatment

The BCR::ABL1 fusion gene plays a key role in the pathogenesis of several blood cancers, particularly chronic myeloid leukemia (CML). This gene results from a chromosomal translocation that causes constitutive... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Microbiology

view channel
Image: The ASTar System has received US FDA 510(k) clearance (Photo courtesy of Q-linea AB)

Automated Sepsis Test System Enables Rapid Diagnosis for Patients with Severe Bloodstream Infections

Sepsis affects up to 50 million people globally each year, with bacteraemia, formerly known as blood poisoning, being a major cause. In the United States alone, approximately two million individuals are... Read more

Pathology

view channel
Image: The new method is quick and easy, and can also be used by non-medical personnel. (Photo courtesy of Zoratto et al. Advanced Science 2024, edited)

New Blood Test Device Modeled on Leeches to Help Diagnose Malaria

Many individuals have a fear of needles, making the experience of having blood drawn from their arm particularly distressing. An alternative method involves taking blood from the fingertip or earlobe,... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.